Back

The present: antibodies siRNAs

30 August 2026 (17:42 - 17:54)
Organised by: Logo
Congress Presentation Part of: Present and the future of PCSK9 inhibition in cardiovascular prevention: from antibodies to gene editing Risk Factors and Prevention ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Kausik K Ray

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
The discovery of PCSK9
Professor C. Boileau (Paris, FR)
Slides Video
Presentation thumbnail
Oral PCSK9 inhibitors
Doctor C. Ballantyne (Houston, US)
Slides Video
Presentation thumbnail
The future: gene editing
Professor A. Zeiher (Frankfurt, DE)
Slides Video
Presentation thumbnail
Present and the future of PCSK9 inhibition in cardiovascular prevention: from antibodies to gene editing - discussion
Video

Access the full session

Session thumbnail
Present and the future of PCSK9 inhibition in cardiovascular prevention: from antibodies to gene editing
Video

The Event

Event poster

ESC Congress 2026

30 August 2026 17:42 CET
You may be interested in
thumbnail
Congress Presentation
siRNAs to lower LDL-cholesterol
28 August 2026
thumbnail
Congress Presentation
Oral PCSK9 inhibitors as an emerging frontier in lipid management: a meta-analysis
29 August 2025
thumbnail
Congress Presentation
Targeting RNA for treatment of dyslipidaemias.
26 August 2022
thumbnail
Congress Presentation
What’s new in LDL lowering?
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources